TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody ...Middle East

HEFEI, China, June 16, 2023 /PRNewswire/ -- TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific...

Hence then, the article about tg immunopharma announces fda clearance for clinical trial of tgi 6 bispecific antibody was published today ( Friday 16/06/2023 - 04:25 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody )

Also on site :

• Japan should lead efforts toward U.S.-Iran ceasefire
• Crew member from downed US fighter jet rescued in 'miraculous' operation, says Trump
• Israel assisted in US rescue mission of downed airman in Iran